TNC and neoplasm: We note here that compared with a cross-reactive control antibody that binds some normal murine tissues (Supplementary Table S3), the use of a nanobody that only recognizes human TNC, may have resulted in preferential apparent tumor selectivity in mouse xenografts and the selectivity for tumor tissues needs additional verification.